These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9626887)

  • 1. Preclinical assessment of hepatocyte-targeted MR contrast agents in stable human liver cell cultures.
    Reimer P; Bader A; Weissleder R
    J Magn Reson Imaging; 1998; 8(3):687-9. PubMed ID: 9626887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a stable cell culture assay for the functional assessment of novel MR contrast agents.
    Reimer P; Bader A; Weissleder R
    Eur Radiol; 1997; 7(4):527-31. PubMed ID: 9204333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents.
    Bader A; Reimer P; Knop E; Böker K; Christians U; Weissleder R; Sewing KF
    Magn Reson Imaging; 1995; 13(7):991-1002. PubMed ID: 8583878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MION-ASF: biokinetics of an MR receptor agent.
    Schaffer BK; Linker C; Papisov M; Tsai E; Nossiff N; Shibata T; Bogdanov A; Brady TJ; Weissleder R
    Magn Reson Imaging; 1993; 11(3):411-7. PubMed ID: 7685055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.
    Moore A; Weissleder R; Bogdanov A
    J Magn Reson Imaging; 1997; 7(6):1140-5. PubMed ID: 9400860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetically labeled cells can be detected by MR imaging.
    Weissleder R; Cheng HC; Bogdanova A; Bogdanov A
    J Magn Reson Imaging; 1997; 7(1):258-63. PubMed ID: 9039625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
    Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
    J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro.
    Schulze E; Ferrucci JT; Poss K; Lapointe L; Bogdanova A; Weissleder R
    Invest Radiol; 1995 Oct; 30(10):604-10. PubMed ID: 8557500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human transferrin receptor gene as a marker gene for MR imaging.
    Moore A; Josephson L; Bhorade RM; Basilion JP; Weissleder R
    Radiology; 2001 Oct; 221(1):244-50. PubMed ID: 11568347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging.
    Reimer P; Weissleder R; Shen T; Knoefel WT; Brady TJ
    Radiology; 1994 Nov; 193(2):527-31. PubMed ID: 7972773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
    Moore A; Marecos E; Bogdanov A; Weissleder R
    Radiology; 2000 Feb; 214(2):568-74. PubMed ID: 10671613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors.
    Weissleder R; Reimer P; Lee AS; Wittenberg J; Brady TJ
    AJR Am J Roentgenol; 1990 Dec; 155(6):1161-7. PubMed ID: 2122660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Organ specific MRI contrast media in general practice].
    Schima W
    Wien Med Wochenschr Suppl; 2002; (113):8-11. PubMed ID: 12621828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes.
    Ketkar-Atre A; Struys T; Dresselaers T; Hodenius M; Mannaerts I; Ni Y; Lambrichts I; Van Grunsven LA; De Cuyper M; Himmelreich U
    Biomaterials; 2014 Jan; 35(3):1015-24. PubMed ID: 24210051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
    Tanimoto A; Kuribayashi S
    Magn Reson Med Sci; 2005; 4(2):53-60. PubMed ID: 16340158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages.
    Schlepper-Schäfer J; Hülsmann D; Djovkar A; Meyer HE; Herbertz L; Kolb H; Kolb-Bachofen V
    Exp Cell Res; 1986 Aug; 165(2):494-506. PubMed ID: 3013664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells.
    Shen TT; Bogdanov A; Bogdanova A; Poss K; Brady TJ; Weissleder R
    Bioconjug Chem; 1996; 7(3):311-6. PubMed ID: 8816953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
    Weissleder R; Lee AS; Fischman AJ; Reimer P; Shen T; Wilkinson R; Callahan RJ; Brady TJ
    Radiology; 1991 Oct; 181(1):245-9. PubMed ID: 1887040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI of blood volume and cellular uptake of superparamagnetic iron in an animal model of choroidal melanoma.
    Krause M; Kwong KK; Xiong J; Gragoudas ES; Young LH
    Ophthalmic Res; 2002; 34(4):241-50. PubMed ID: 12297697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.